Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,515.20
(
0.31%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
-0.89%
)
Bitcoin
73,325.69
(
-0.29%
)
News Focus
News Focus
Post# of 70421
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Rowdy2

Send PM Follow Ignore
Followers 2
Posts 607
Boards Moderated 0
Alias Born 12/04/2018

Rowdy2

Re: ZenMan 111 post# 43758

Tuesday, 02/26/2019 2:18:47 PM

Tuesday, February 26, 2019 2:18:47 PM

Post# of 70421
HEXO received no capital injection of cash, they just did a joint venture with Molson Coors, and as a result it did not affect the share price of the stock. Their stock has appreciated due to the company's own efforts and business strategy.

Removing the capital injection that CGC and CRON received, they are still trading at levels above what they were trading at this time last year. It is only ACB that is down due to their "dilution spree", mediocre products, and poor business model.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ACB News
More ACB News